Ann: Full Year Statutory Accounts, page-8

So there's expected delays with KOL reports, as covid had caused the closure of IVF clinics worldwide.

Which is no surprise. We all new this would happen. Aiming early CY 2021. Not required for initial sales in certain countries.

Still on track for initial commercialisation end of CY 2020 in Canada, with requirements for japan India and New Zealand sales nearing completion.

Planning for presubmission meeting to FDA.

Study required for TGA approval to start after V+V early CY 2021.

Ramping up developing system for animals.

All cashed up for commercialisation.

Honestly nothing surprising that I can see. Minimal delays which is nice, especially to the most important thing and that is initial commercialisation.

Disappointed about KOL delays but given it's a global pandemic they're forgiven by me at least.

A couple announcements to look forward to in the next couple months.

Happy holder here. I don't need to be rich right now. I can wait a year or two